122 related articles for article (PubMed ID: 9560199)
1. Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation.
Li D; Sun XL; Casto B; Fang J; Theil K; Glaser R; Milo G
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4894-9. PubMed ID: 9560199
[TBL] [Abstract][Full Text] [Related]
2. Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene.
Li D; Yan H; Chen J; Casto BC; Theil KS; Milo GE
Carcinogenesis; 1996 Aug; 17(8):1751-5. PubMed ID: 8761437
[TBL] [Abstract][Full Text] [Related]
3. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
4. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
[TBL] [Abstract][Full Text] [Related]
5. A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell line.
Fujita M; Shiku H
FEBS Lett; 1993 May; 322(1):15-20. PubMed ID: 8387025
[TBL] [Abstract][Full Text] [Related]
6. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
Gutsch DE; Marcu KB; Kenney SC
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
[TBL] [Abstract][Full Text] [Related]
8. Metastatic conversion of chemically transformed human cells.
Sun XL; Li D; Fang J; Casto B; Noyes I; Milo GE
Gene Expr; 1999; 8(5-6):327-39. PubMed ID: 10947081
[TBL] [Abstract][Full Text] [Related]
9. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
Mautner J; Behrends U; Hörtnagel K; Brielmeier M; Hammerschmidt W; Strobl L; Bornkamm GW; Polack A
Oncogene; 1996 Mar; 12(6):1299-307. PubMed ID: 8649832
[TBL] [Abstract][Full Text] [Related]
10. Malignant conversion of chemically transformed normal human cells.
Milo GE; Li D; Casto BC; Theil K; Shuler C; Noyes I; Chen J
Proc Natl Acad Sci U S A; 1996 May; 93(11):5229-34. PubMed ID: 8643558
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
12. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
13. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity.
Scala G; Quinto I; Ruocco MR; Arcucci A; Mallardo M; Caretto P; Forni G; Venuta S
J Exp Med; 1990 Jul; 172(1):61-8. PubMed ID: 2162905
[TBL] [Abstract][Full Text] [Related]
14. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells.
Cherney BW; Bhatia K; Tosato G
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12967-71. PubMed ID: 7809156
[TBL] [Abstract][Full Text] [Related]
15. [Expression of c-myc gene and biosynthesis of biological macromolecules in antisense transfectant HLR60-9].
Li Y; Fan M; Zhang J
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):16-9. PubMed ID: 8732104
[TBL] [Abstract][Full Text] [Related]
16. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
Kinoshita T
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
[TBL] [Abstract][Full Text] [Related]
17. Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell line.
Zhao X; Wang X; Zhou C; Peng R; Yan S; Wu M
Sci China B; 1995 May; 38(5):580-9. PubMed ID: 7626199
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
19. Changes in levels of normal ML-1 gene transcripts associated with the conversion of human nontumorigenic to tumorigenic phenotypes.
Sun XL; Li D; Fang J; Noyes I; Casto B; Theil K; Shuler C; Milo GE
Gene Expr; 1999; 8(2):129-39. PubMed ID: 10551800
[TBL] [Abstract][Full Text] [Related]
20. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
